Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages

被引:355
作者
Freire-de-Lima, CG
Nascimento, DO
Soares, MBP
Bozza, PT
Castro-Faria-Neto, HC
de Mello, FG
DosReis, GA [1 ]
Lopes, MF
机构
[1] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944970 Rio De Janeiro, Brazil
[2] Fiocruz MS, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil
[3] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil
关键词
D O I
10.1038/35003208
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
After apoptosis, phagocytes prevent inflammation and tissue damage by the uptake and removal of dead cells(1). In addition, apoptotic cells evoke an anti-inflammatory response through macrophages(2,3). We have previously shown that there is intense lymphocyte apoptosis in an experimental model of Chagas' disease(4), a debilitating cardiac illness caused by the protozoan Trypanosoma cruzi. Here we show that the interaction of apoptotic, but not necrotic T lymphocytes with macrophages infected with I: cruzi fuels parasite growth in a manner dependent on prostaglandins, transforming growth factor-beta (TGF-beta) and polyamine biosynthesis. We show that the vitronectin receptor is critical, in both apoptotic-cell cytoadherence and the induction of prostaglandin E-2/TGF-beta release and ornithine decarboxylase activity in macrophages. A single injection of apoptotic cells in infected mice increases parasitaemia, whereas treatment with cyclooxygenase inhibitors almost completely ablates it in vivo. These results suggest that continual lymphocyte apoptosis and phagocytosis of apoptotic cells by macrophages have a role in parasite persistence in the host, and that cyclooxygenase inhibitors have potential therapeutic application in the control of parasite replication and spread in Chagas' disease.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 29 条
  • [1] BOUTARD V, 1995, J IMMUNOL, V155, P2077
  • [2] PGE(2) INVOLVEMENT IN EXPERIMENTAL-INFECTION WITH TRYPANOSOMA-CRUZI SUBPOPULATIONS
    CELENTANO, AM
    GORELIK, G
    SOLANA, ME
    STERINBORDA, L
    BORDA, E
    CAPPA, SMG
    [J]. PROSTAGLANDINS, 1995, 49 (03): : 141 - 153
  • [3] INVITRO DIFFERENTIATION OF TRYPANOSOMA-CRUZI UNDER CHEMICALLY DEFINED CONDITIONS
    CONTRERAS, VT
    SALLES, JM
    THOMAS, N
    MOREL, CM
    GOLDENBERG, S
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1985, 16 (03) : 315 - 327
  • [4] Involvement of protein kinase A in the induction of arginase in murine bone marrow-derived macrophages
    Corraliza, IM
    Modolell, M
    Ferber, E
    Soler, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1997, 1334 (2-3): : 123 - 128
  • [5] De Mello F G, 1976, J Neurochem, V27, P847
  • [6] Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF
    Fadok, VA
    Bratton, DL
    Konowal, A
    Freed, PW
    Westcott, JY
    Henson, PM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 890 - 898
  • [7] SELECTIVE-INHIBITION OF NS-398 ON PROSTANOID PRODUCTION IN INFLAMED TISSUE IN RAT CARRAGEENAN-AIR-POUCH INFLAMMATION
    FUTAKI, N
    ARAI, I
    HAMASAKA, Y
    TAKAHASHI, S
    HIGUCHI, S
    OTOMO, S
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (08) : 753 - 755
  • [8] THE MICROBICIDAL ACTIVITY OF INTERFERON-GAMMA-TREATED MACROPHAGES AGAINST TRYPANOSOMA-CRUZI INVOLVES AN L-ARGININE-DEPENDENT, NITROGEN OXIDE-MEDIATED MECHANISM INHIBITABLE BY INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA
    GAZZINELLI, RT
    OSWALD, IP
    HIENY, S
    JAMES, SL
    SHER, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) : 2501 - 2506
  • [9] ANALYSIS OF NITRATE, NITRITE, AND [N-15]-LABELED NITRATE IN BIOLOGICAL-FLUIDS
    GREEN, LC
    WAGNER, DA
    GLOGOWSKI, J
    SKIPPER, PL
    WISHNOK, JS
    TANNENBAUM, SR
    [J]. ANALYTICAL BIOCHEMISTRY, 1982, 126 (01) : 131 - 138
  • [10] CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
    Griffith, TS
    Yu, XH
    Herndon, JM
    Green, DR
    Ferguson, TA
    [J]. IMMUNITY, 1996, 5 (01) : 7 - 16